GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EQL Pharma AB (XSAT:EQL) » Definitions » PEG Ratio

EQL Pharma AB (XSAT:EQL) PEG Ratio

: 0.38 (As of Today)
View and export this data going back to 2013. Start your Free Trial
PE Ratio without NRI / 5-Year EBITDA Growth Rate*

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The growth rate we use is the 5-Year EBITDA growth rate. As of today, EQL Pharma AB's PE Ratio without NRI is 43.06. EQL Pharma AB's 5-Year EBITDA growth rate is 114.30%. Therefore, EQL Pharma AB's PEG Ratio for today is 0.38.

* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


The historical rank and industry rank for EQL Pharma AB's PEG Ratio or its related term are showing as below:

XSAT:EQL' s PEG Ratio Range Over the Past 10 Years
Min: 0.17   Med: 0.4   Max: 43.92
Current: 0.38


During the past 11 years, EQL Pharma AB's highest PEG Ratio was 43.92. The lowest was 0.17. And the median was 0.40.


XSAT:EQL's PEG Ratio is ranked better than
91.96% of 373 companies
in the Drug Manufacturers industry
Industry Median: 1.64 vs XSAT:EQL: 0.38

Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.


EQL Pharma AB PEG Ratio Historical Data

The historical data trend for EQL Pharma AB's PEG Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EQL Pharma AB Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
PEG Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 7.59 0.46 0.36

EQL Pharma AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PEG Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.36 0.25 0.25 0.38

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, EQL Pharma AB's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EQL Pharma AB PEG Ratio Distribution

For the Drug Manufacturers industry and Healthcare sector, EQL Pharma AB's PEG Ratio distribution charts can be found below:

* The bar in red indicates where EQL Pharma AB's PEG Ratio falls into.



EQL Pharma AB PEG Ratio Calculation

PEG Ratio is defined as the PE Ratio without NRI divided by the growth ratio. The ratio we use is the 5-Year EBITDA growth rate.

EQL Pharma AB's PEG Ratio for today is calculated as

PEG Ratio=PE Ratio without NRI/5-Year EBITDA Growth Rate*
=43.061224489796/114.30
=0.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.


EQL Pharma AB  (XSAT:EQL) PEG Ratio Explanation

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.


EQL Pharma AB PEG Ratio Related Terms

Thank you for viewing the detailed overview of EQL Pharma AB's PEG Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


EQL Pharma AB (XSAT:EQL) Business Description

Traded in Other Exchanges
Address
Stortorget 1, 3rd Floor, Lund, SWE, 222 23
EQL Pharma AB is a pharmaceutical company engaged in developing and selling medicines to pharmacies and hospitals. The products offered by the company include generics and parallel imports. It operates and markets products to Nordic countries of Sweden, Denmark, Finland and Norway.

EQL Pharma AB (XSAT:EQL) Headlines

From GuruFocus